Showing 4661-4670 of 5910 results for "".
- Adverum Provides Update on ADVM-022 and the INFINITY Trial in Patients with Diabetic Macular Edemahttps://modernod.com/news/adverum-provides-update-on-advm-022-and-the-infinity-trial-in-patients-with-diabetic-macular-edema/2479404/Adverum Biotechnologies provided an update on the ADVM-022 development program following a thorough review of data available from the INFINITY clinical trial in patients with diabetic macular edema (DME) and the OPTIC clinical trial in patients with wet age-related macular degeneration (AMD). The
- Johnson & Johnson Vision Launches Veritas Vision Systemhttps://modernod.com/news/johnson-johnson-vision-introduces-veritas-vision-system-with-features-to-address-key-unmet-needs-in-cataract-surgery/2479401/Johnson & Johnson Vision announced the global availability of the Veritas Vision System, a next-generation phacoemulsification system designed to address three critical areas: patient safety, surgeon efficiency and comfort. The company will offer live demos of the new system in a wet lab at t
- ArcScan Signs Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technologyhttps://modernod.com/news/arcscan-signs-agreement-for-11-15-million-preferred-series-b-investment-with-shanghai-haohai-biological-technology/2479394/ArcScaan announced the execution of a Stock Purchase Agreement with Shanghai Haohai Biological Technology that will result in a $11.15 million Preferred Series B investment into ArcScan. Haohai is a leading Chinese ophthalmology and medical aesthetics company headquartered in Shanghai, and is pub
- Allergan to Present New Data from its Eye Care Portfolio at the 2021 ASCRShttps://modernod.com/news/allergan-to-present-new-data-from-its-eye-care-portfolio-at-the-2021-ascrs/2479386/Allergan announced that it will present new data from its leading portfolio of eye care medicines at the 2021 ASCRS (American Society for Cataract and Refractive Surgery) annual meeting being held July 23-27 in Las Vegas. Presentations will include new data on AGN-190584 (pilocarpine 1.25%), an i
- Euclid Systems Appoints Vance Thompson, MD, as Chief Medical Officerhttps://modernod.com/news/euclid-systems-appoints-vance-thompson-md-as-chief-medical-officer/2479383/Euclid Systems announced that it has appointed Vance Thompson, MD, an internationally recognized authority in laser vision correction and advanced cataract surgery, to the position of Chief Medical Officer. As an international researcher, Dr. Thompson has played a key role in the development of a
- Allegro Ophthalmics to Present the Results of ALG-1007 Ex-U.S. Phase 2 Clinical Trial for Dry Eye Disease at ASCRShttps://modernod.com/news/allegro-ophthalmics-to-present-the-results-of-alg-1007-ex-u-s-phase-2-clinical-trial-for-dry-eye-disease-at-ascrs/2479379/Allegro Ophthalmics announced that the results of the company’s second ALG-1007 ex-U.S. clinical trial for the treatment of dry eye disease (DED) will be presented during the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators (ASCRS ASOA) an
- iSTAR Medical Receives FDA Approval to Begin Trial for MINIject for Patients With Glaucomahttps://modernod.com/news/istar-medical-receives-fda-approval-to-begin-trial-for-miniject-for-patients-with-glaucoma/2479375/iSTAR Medical announced that the FDA granted it investigational device exemption (IDE) to start a trial with MINIject. The STAR-V study will investigate MINIject in over 350 patients with primary open-angle glaucoma. Glaucoma surgeons in the United States, Canada, and Europe will join the trial.<
- Hoya Vision Care and Myopia Profile Training the Visionaries of the Futurehttps://modernod.com/news/hoya-vision-care-and-myopia-profile-training-the-visionaries-of-the-future/2479370/Hoya Vision Care announced the roll out of a suite of co-created certified training courses to educate, inform and empower eye care professionals (ECPs) to prescribe spectacle lenses for children in the global fight t
- First Eye Care-Focused SPAC, LifeLong Vision, Launchedhttps://modernod.com/news/first-eye-care-focused-spac-lifelong-vision-to-host-launch-event/2479368/A new multi-billion dollar initiative that aims to provide daily access to eye care through any mobile device officially launched on Wednesday. LifeLong Vision, which is backed by investment banking platform MedHealth Capital, is set to emerge via a Special Purpose Acquisition Company (SPA
- CATS Tonometer Receives FDA Clearance for Disposable Tonometer Prismhttps://modernod.com/news/cats-tonometer-receives-fda-clearance-for-disposable-tonometer-prism/2479364/The CATS-D Disposable Prism, designed to deliver improved IOP measurement accuracy using a sterile, disposable tip replacement for the Goldmann Tonometer, received FDA clearance and will be available for sale in the fall of 2021. “The CATS Tonometer Prism is designed to provide more accura